VH gene use by HIV type 1-associated lymphoproliferations
- PMID: 9007199
- DOI: 10.1089/aid.1997.13.135
VH gene use by HIV type 1-associated lymphoproliferations
Abstract
The pathogenesis of polyclonal HIV-associated lymphomas lacking traditional B cell cofactors (i.e., Epstein-Barr virus [EBV] infection, c-myc translocations) is poorly understood. A multistep pathogenesis model has been proposed in which polyclonal lymphomas represent an earlier stage in HIV-associated lymphomagenesis before the emergence of a dominant malignant clone. Chronically present antigens have been proposed as a likely stimulus for polyclonal B cell proliferation; if so, polyclonal lymphoma-associated immunoglobulins (Igs) should have molecular evidence of somatic hypermutation, a process by which antibody affinity maturation in response to chronic antigenic stimulation occurs. Molecular analyses of Ig heavy chain variable (V(H)) gene use by B cells in a polyclonal HIV-associated large cell lymphoma lacking EBV and c-myc rearrangement was undertaken. Eighteen randomly selected clones generated from RT-PCR yielded 15 unique V(H) sequences, all of which were most homologous to only three previously identified germline V(H)1 genes. Two sets of clones (consisting of three and two clones, respectively) had identical V(H) gene sequences, and one pair of clones had identical third complementarity determining regions (CDR3s) but different V(H) gene sequences; eight clones were <95% homologous to their most related germline V(H)1 genes. We compared these results with Ig V(H)1 gene use by B cells present in a reactive hyperplastic lymph node obtained from an HIV-1-infected individual. Fifteen clones randomly selected from RT-PCRs yielded 15 unique V(H)1 sequences, all of which were most homologous to 5 previously identified germline V(H)1 genes; 10 clones were <95% homologous to their most related germline gene. Binomial probability analysis revealed that only 1 of the 15 unique V(H)1 sequences derived from the polyclonal lymphoma (i.e., 7%), as compared with 5 of 15 unique V(H)1 sequences derived from the reactive lymph node (i.e., 33%), had a low probability of occurrence by random chance (p < 0.05). These data provide molecular evidence of polyclonality in an HIV-associated polyclonal lymphoma, demonstrate a qualitative difference in somatic hypermutations of Ig V(H) genes associated with malignant versus reactive B cell lymphoproliferations, and support an antigen-mediated multistep pathogenesis model of HIV-1-associated lymphomagenesis.
Similar articles
-
Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution.Hum Immunol. 2000 Dec;61(12):1242-53. doi: 10.1016/s0198-8859(00)00181-6. Hum Immunol. 2000. PMID: 11163079
-
Evidence for early B-cell activation preceding the development of Epstein-Barr virus-negative acquired immunodeficiency syndrome-related lymphoma.Blood. 1996 Dec 15;88(12):4620-9. Blood. 1996. PMID: 8977254
-
IgMs produced by two acquired immune deficiency syndrome lymphoma cell lines: Ig binding specificity and VH-gene putative somatic mutation analysis.Blood. 1994 Feb 15;83(4):1067-78. Blood. 1994. PMID: 8111047
-
The immunology of AIDS-associated lymphomas.Immunol Rev. 1998 Apr;162:293-8. doi: 10.1111/j.1600-065x.1998.tb01449.x. Immunol Rev. 1998. PMID: 9602372 Review.
-
Human antibody variable region gene usage in HIV-1 infection.J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):31-8. doi: 10.1097/00042560-199601010-00004. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8528730 Review.
Cited by
-
The AIDS and Cancer Specimen Resource: role in HIV/AIDS scientific discovery.Infect Agent Cancer. 2007 Mar 2;2:7. doi: 10.1186/1750-9378-2-7. Infect Agent Cancer. 2007. PMID: 17335575 Free PMC article.
-
HIV-1 Nef in macrophage-mediated disease pathogenesis.Int Rev Immunol. 2012 Dec;31(6):432-50. doi: 10.3109/08830185.2012.737073. Int Rev Immunol. 2012. PMID: 23215766 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous